R Ananthanarayanan appointed as CEO, MD of Strides
Strides Pharma Science on 8th January, 2019 announced that the company has decided to bring on board R Ananthanarayanan as […]
Say something
Strides Pharma Science on 8th January, 2019 announced that the company has decided to bring on board R Ananthanarayanan as […]
Strides Pharma Science has acquired 70 percent stake in a Switzerland-based Fairmed Healthcare AG for over 15.50 crore. The company’s […]